Treatment Adherence and Health-Related Quality of Life Among Patients with Hypertension at Tertiary Healthcare Facility in Lalitpur, Nepal: A Cross-Sectional Study
Open Access
- 1 October 2024
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 18, 2077-2090
Abstract
Background: Measurement of medication adherence and health-related quality of life is extremely important when planning different health policies. Drug therapy and adherence to medication are critical to prevent complications of hypertension, especially in countries like Nepal, where hypertension is one of the most prevalent diseases. However, this has not been studied in Nepal. This study, hence, aimed to explore medication adherence, factors affecting medication adherence, health-related quality of life, and the correlation between medication adherence and health-related quality of life in hypertensive patients visiting tertiary care health facilities in Lalitpur district of Nepal. Methodology: This quantitative cross-sectional study was conducted among 380 hypertensive patients at KIST Medical College and Teaching Hospital, Lalitpur, Nepal. The Nepali version of the European Quality of Life tool EQ-5D-5L and the Hill-Bone Compliance to High Blood Pressure Therapy Scale (HBCTS) were used. Intergroup differences in medication adherence, the EQ-5D index and EQ-VAS scores were assessed for statistical significance using either the Mann–Whitney or Kruskal–Wallis tests for numerical data. Spearman correlation coefficient was used to identify the relationship among medication adherence, EQ-5D-5L index values, and EQ-VAS scores. Results: The mean treatment score was 22.43 ± 4.12. Age, sex, and occupation were significant factors that affected treatment adherence. The EQ-5D score was 0.72 with age, sex, income, and educational status as significant factors and marital status as an insignificant factor. A slightly negative correlation was found between the total treatment adherence score and the EQ-5D index. Conclusion: The treatment adherence of patients to antihypertensive therapy was suboptimal, which could affect the outcome of therapy. Better treatment adherence was correlated with a better health-related quality of life. Hence, both health-care providers and patients should make efforts to increase treatment adherence to attain better HRQOL.Keywords
This publication has 70 references indexed in Scilit:
- Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional surveyQuality of Life Research, 2018
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- Valuing health-related quality of life: An EQ-5D-5L value set for EnglandHealth Economics, 2017
- Obesity2017
- Quality of life of patient with hypertension in KathmanduInternational Journal of Nursing Sciences, 2016
- Health-related quality of life associated with treatment adherence in patients with hypertension: A cross-sectional studyInternational Journal of Cardiology, 2013
- Methodological issues in measuring health-related quality of lifeTzu Chi Medical Journal, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric propertiesJournal of Clinical Epidemiology, 2010
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002